Mistletoe Lectin I-Induced Effects on Human Cytotoxic Lymphocytes. I. Synergism with Il-2 in the Induction of Enhanced Lak Cytotoxicity
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 20 (3) , 355-372
- https://doi.org/10.3109/08923979809034819
Abstract
This report demonstrates that in vitro activation of human cells with the beta-galactoside-specific lectin from mistletoe (ML-I) or interleukin-2 (IL-2) results in different patterns of activation and function of cytotoxic cells. It is now well established that natural killer (NK) and lymphokine-activated killer (LAK) cytotoxicity is mainly mediated by resting (NK) and IL-2-activated (LAK) CD56-positive (+) cells respectively. Culture of peripheral blood lymphocytes (PBL) for 3 days with ML-I led to expansion and activation of T cells which demonstrated NK- and LAK-like cytotoxicity. T lymphocyte subset analysis revealed that in total PBL, ML-I preferentially stimulated and expanded CD8+ T cells which mediated the cytotoxic effect. Incubation of highly purified CD8+ T cells alone with ML-I did not lead to induction of cytotoxicity, which required the presence of both CD4+ and CD14+ (monocytes) cells, suggesting that ML-I does not exert a direct effect on CD8+ T cells. Activation of PBL with both ML-I and IL-2 resulted in simultaneous induction of T and CD56+ cell-mediated NK and LAK cytotoxicity. These data suggest that treatment with ML-I and IL-2 might provide an approach to induce maximum cytotoxicity against tumors and to recruit both T and NK cells for tumor therapy.Keywords
This publication has 18 references indexed in Scilit:
- Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage–colony stimulating factorCancer, 1995
- Interleukin 1 β synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectorsBritish Journal of Cancer, 1994
- Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapyCritical Reviews in Oncology/Hematology, 1994
- 7 Cytokine gene transfer in the therapy of malignancyBailliere's Clinical Haematology, 1994
- Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancerCancer, 1993
- Sister-chromatid exchange in highly purified human CD4+ and CD8+ lymphocytesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patientsJournal of Molecular Medicine, 1992
- Isolation and properties of three lectins from mistletoe (Viscum album L.)Biochemical Journal, 1981
- The lectin fromViscum album L. purification by biospecific affinity chromatographyCellular and Molecular Life Sciences, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970